Editor
UnitedHealth Group’s pharmacy benefit manager will cover up to three biosimilars that compete with AbbVie’s costly drug Humira next year, the company disclosed Tuesday.
The rheumatoid arthritis treatment is the highest-grossing pharmaceutical of all time and the largest contributor to drug price inflation, according to a congressional investigation. A year-long course of the brand-name biologic drug can cost more than $84,000. Competing…
